NASDAQ:ESPR - Esperion Therapeutics, Inc.
$44.88
 $0.38
+0.85%
2:05PM EDT
2019-02-15
Esperion Therapeutics, Inc. is a lipid management company. The Company is a late-stage pharmaceutical company focused on developing and commercializing once-daily, oral therapies for the treatment of patients with elevated low-density lipoprotein cholesterol (LDL-C). With a targeted mechanism of action, bempedoic acid, the Company's lead product candidate, is an orally available, once-daily adenosine triphosphate (ATP)-citrate lyase (ACL) inhibitor that reduces cholesterol biosynthesis and lowers elevated levels of LDL-C by up-regulating the LDL receptor, but with reduced potential for muscle-related side effects. In addition to bempedoic acid as monotherapy, the Company is also developing bempedoic acid in a fixed dose combination with ezetimibe, an approved, non-statin, oral, LDL-C lowering therapy. As of December 31, 2016, the Company was engaged in conducting its global Phase III clinical development program for bempedoic acid. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  ESPR     avg for
industry  
  avg for
sector  
42 stocks weight:  37. 68   0. 00   0. 00  
42 stocks rank:  3. 08 K 1. 86 K 1. 09 K
# analyst opinions:  14. 00   14. 92   14. 43  
mean recommendation:  2. 10   1. 91   1. 93  

quick ratio:  3. 77   5. 37   1. 81  
current ratio:  3. 98   5. 69   2. 19  

target price low:  32. 50   88. 97   117. 82  
target price avg:  48. 70   115. 19   141. 96  
target price high:  80. 89   143. 40   163. 16  
1-yr high:  80. 75   124. 30   142. 77  
last close:  44. 50   101. 85   127. 84  
50-day avg:  45. 61   98. 27   122. 46  
200-day avg:  45. 14   99. 72   122. 70  
1-yr low:  36. 20   78. 19   100. 16  
volume:  310. 82 K 2. 38 M 4. 64 M
50-day avg volume:  561. 43 K 3. 31 M 4. 94 M
200-day avg volume:  884. 76 K 3. 23 M 4. 28 M

1-day return:  -4. 42 % 0. 22 % 0. 48 %
this week return:  -1. 70 % 1. 77 % 2. 01 %
12-wk return:  -11. 30 % 6. 56 % 3. 33 %
52-wk return:  -33. 79 % -2. 23 % 14. 35 %

enterprise value (EV):  1. 05 B 55. 17 B 104. 51 B
market cap:  1. 19 B 49. 01 B 96. 46 B
EBITDA:  -182. 38 M 4. 82 B 7. 18 B
enterprise multiple (EV/EBITDA):  -5. 78   -91. 79   2. 29  
total debt:  0. 00   13. 73 B 16. 57 B
net income (common):  -179. 66 M 2. 37 B 3. 58 B

shares outstanding:  26. 81 M 607. 99 M 1. 22 B
shares:  21. 77 M 605. 53 M 1. 15 B
shares short:  5. 90 M 11. 62 M 12. 55 M
shares short prior month:  5. 49 M 11. 95 M 13. 44 M
short ratio:  7. 08   4. 82   3. 10  
short % of float:  24. 32 % 6. 19 % 2. 82 %
total cash/share:  5. 94   12. 02   11. 46  
total cash:  159. 22 M 7. 41 B 7. 37 B
free cash flow:  -89. 14 M 95. 99 M 2. 04 B
operating cash flow:  -154. 82 M 164. 74 M 3. 04 B

book value:  4. 92   14. 43   28. 26  
price/book:  9. 05   -1. 57   -2. 97  
operating margins:  0. 00 % -458. 01 % -642. 83 %
EBITDA margins:  0. 00 % 13. 81 % 22. 47 %
profit margins:  0. 00 % 6. 57 % 9. 92 %
gross margins:  0. 00 % 49. 33 % 54. 53 %

1-yr max volatility:  -35. 11 % --- ---
1-yr mean volatility:  -0. 09 % 0. 01 % 0. 06 %

1-yr EPS:  -6. 75   3. 03   4. 09  
forward EPS:  -4. 79   4. 33   6. 99  
P/E:  -6. 59   6. 11   26. 91  
forward P/E:  -9. 45   8. 38   10. 48  
PE/G:  0. 60   0. 37   5. 61  
growth:  -10. 97 % 683. 72 % 104. 79 %
earnings high:  -1. 05   1. 27   1. 66  
earnings avg:  -1. 42   1. 01   1. 53  
earnings low:  -1. 84   0. 76   1. 40  
revenue high:  -0. 00   2. 86 B 11. 19 B
revenue avg:  -0. 00   2. 78 B 10. 84 B
revenue low:  -0. 00   2. 67 B 10. 64 B
return on assets:  -46. 87 % -3. 27 % 3. 81 %
return on equity:  -87. 67 % 107. 48 % 27. 82 %

beta (1yr vs S&P500):  1. 52   1. 21   0. 93  
sharpe (1yr):  -0. 33   0. 06   0. 98  

held % insiders:  5. 10 % 6. 46 % 3. 21 %
held % institutions:  117. 06 % 79. 10 % 70. 01 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-02-14 : ESPR
.        + 0 =             0 :: INITIAL WEIGHT
.  + 203.374 =       203.374 :: inverse volume-to-price addition
.  + 343.454 =       546.828 :: spline projection addition
.  - 144.793 =       402.035 :: poor performance penalty
.    x 0.775 =       311.543 :: one-year gains+dividend factor
.    x 2.937 =       915.094 :: 13 weeks' performance factor
.    x 1.492 =      1365.767 :: industry recommendation factor
.    x 2.079 =      2839.729 :: symbol recommendation factor
.    x 0.995 =      2826.421 :: return on assets factor
.    x 0.991 =      2801.641 :: return on equity factor
.    x 2.699 =      7560.741 :: current ratio factor
.    x 1.167 =      8822.655 :: quick ratio factor
.    x 1.068 =      9425.152 :: short ratio factor
.    x 2.188 =     20621.454 :: price-to-book factor
.     x 1.01 =     20818.581 :: 5-day avg > 200-day avg
.     x 1.01 =     21031.243 :: 50-day avg > 200-day avg
.    x 2.133 =     44869.535 :: P/E weight
.    x 1.136 =     50958.047 :: PE/G factor
.     x 1.66 =     84604.599 :: beta factor
.    x 0.334 =     28278.544 :: sharpe factor
.    x 0.948 =     26810.065 :: target low factor
.    x 1.102 =     29556.025 :: target mean factor
.     x 1.09 =     32228.767 :: target high factor
.    x 1.066 =     34343.387 :: industry 12-weeks return
.     x 0.98 =     33647.072 :: "drift" penalty 3 days ago
.    x 0.931 =     31314.593 :: "drift" penalty 5 days ago
.    x 0.992 =     31072.395 :: overall "drift" factor
.    x 0.999 =     31027.319 :: largest single-day jump factor
.     x 1.01 =     31337.301 :: mean volatility factor
.    x 1.097 =     34383.707 :: 42-day mean volatility factor
.      x 1.0 =     34386.015 :: factor hist industry gain for week 06
.    x 1.556 =     53510.841 :: upcoming earnings report factor
.   cubeRoot =        37.683 :: reduced for readability
.                     37.683 :: FINAL WEIGHT for NASDAQ:ESPR


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org